USE/OCC TX-EXEMPT PRESCRIPTION

Summary

The bill removes state sales, use, service, and retailer occupation taxes on prescription medicines and FDA Class III medical devices that are prescribed for cancer treatment. It also increases the portion of income‑tax revenue that is sent to the Local Government Distributive Fund to 7.47% for individuals and pass‑through entities and 7.85% for corporations, starting July 1 2026. The changes aim to lower costs for cancer patients while providing more funding to local governments.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share